Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study

Published:2017-12 Issue:6 Volume:37 Page:943-947
ISSN:2096-5230
Container-title:Current Medical Science
language:en
Short-container-title:CURR MED SCI

Author:

Xie Fang,Wang Rui,Zhao Zi-gang,Meng Xian-fu,Lin Bi-wen,Yang Jie,Wang Wen-juan,Ding Xiang-yu,Yang Yi,Zhao Hua,Li Cheng-xin,Li Heng-jin,Zhou Yong

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry

Link

http://link.springer.com/article/10.1007/s11596-017-1832-7/fulltext.html

Reference28 articles.

1. Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs. Arch Dermatol, 2010,146(1):46–54

2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet, 2007,370(9583):263–271

3. Liu XX, Feng AP, He YM, et al. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis. J Huazhong Univ Sci Technol [Med Sci], 2016,36(1):132–136

4. Busard C, Zweegers J, Limpens J, et al. Combined use of systemic agents for psoriasis: a systematic review. JAMA Dermatol, 2014,150(11):1213–1220

5. Ghoreschi K, Weigert C, Rocken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol, 2007,25(6):574–580

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete remission of Psoriatic erythroderma using modified low dose etanercept in a HIV positive patient: A case report with review of literature;Dermatologic Therapy;2021-03-18

2. IL-1β, IL-17A and combined phototherapy predicts higher while previous systemic biologic treatment predicts lower treatment response to etanercept in psoriasis patients;Inflammopharmacology;2018-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3